Patent classifications
A61B2017/00053
Systems, methods, and devices for monitoring and treatment of tissues within and/or through a lumen wall
A system for controlled sympathectomy procedures is disclosed. A system for controlled micro ablation procedures is disclosed. Methods for performing a controlled surgical procedure are disclosed. A system for performing controlled surgical procedures in a minimally invasive manner is disclosed. Systems and methods for accessing target tissues as part of a neuromodulation procedure from within a lumen are disclosed.
Expandable elements for delivery of electric fields
A method, system, and device for electroporation. A system may include a medical device with a plurality of electrodes borne on an expandable element and an energy generator in communication with the electrodes. The energy generator may have processing circuitry configured to selectively deliver electroporation energy to at least one of the electrodes. The processing circuitry may determine whether an alert condition is present and, if so, cease the delivery of electroporation energy to one or more electrodes identified as the cause of the alert condition and/or prevent the delivery of electroporation energy to the one or more electrodes identified as the cause of the alert condition. The energy generator may also be configured to deliver electroporation energy in a sequence of a plurality of energy delivery patterns to enhance lesion formation.
CHEMICAL ABLATION APPARATUS FOR TREATING ARRHYTHMIA
The disclosure relates to a chemical ablation apparatus for treating arrhythmia, comprising: a clamp body, a clamp head consisting of a pair of clamp jaws, a needle head assembly, a needle head extension and retraction control assembly, pipeline components, and an electrocardiographic mapping component. The chemical ablation apparatus can control needle heads to extend out of or retract into the clamp head by means of the needle head extension and retraction control assembly. A chemical ablation reagent may be injected to a cardiac muscle tissue to conveniently achieve complete ablation of the cardiac muscle tissue by applying a chemical ablation method. The ablation effect can be verified by the electrocardiographic mapping system, to thereby increase the success rate and lower the difficulty level of arrhythmia ablation operations, while also reducing the manufacturing cost of the ablation apparatus and corollary equipment thereof, and decreasing the expenses for atrial fibrillation surgical operations.
Spine construction for basket catheter
A spine of an electrode assembly is constructed by simultaneously deploying a plurality of individual bobbins of lead wire radially around the longitudinal axis of a polymeric tube. A free end of lead wire from each bobbin is electrically connected to a respective electrode and the electrodes are sequentially installed from a distal first location on the polymeric tube to a proximal location. Each lead wire may be helically wound around the polymeric tube between the electrode to which the lead wire is electrically connected and a proximally adjacent electrode, such that each lead wire between adjacent pairs of electrodes has an alternating direction of winding.
Analyzing and mapping ECG signals and determining ablation points to eliminate Brugada syndrome
A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation. The method may further comprise preparing an updated epicardial map comprising maintaining anatomical volume data and adding electroanatomical data.
Methods, Systems, Devices, and Components for Visualizing Electrographic Flow (EGF)
Electrographic flow mapping (EGF mapping) is a technique used for aiding catheter ablation when treating atrial fibrillation. Visualizing EGF fields during a cardiac catherization and ablation procedure is an important and necessary part of conducting the procedure. Several different visualization methods are described and disclosed herein that may be employed to visualize EGF fields and maps, including quiver plots, streamline plots, particle plots, particle trail plots, moving particle plots, and moving and fading particle plots.
Pulsed radiofrequency ablation
Ablation systems and methods of the present disclosure are directed toward delivering pulsed radiofrequency (RF) energy to target tissue. The pulsations of the RF energy, combined with cooling at a surface of the target tissue, can advantageously promote local heat transfer in the target tissue to form lesions having dimensions larger than those that can be safely formed in tissue using non-pulsed RF energy under similar conditions.
PLANETARY GEAR ASSEMBLY FOR SPUTTERING MULTIPLE BALLOON CATHETER DISTAL ENDS
An apparatus includes an assembly and hollow templates. The assembly includes multiple rods or shafts mounted thereon. The assembly is configured to rotate about a first axis, and each of the rods or shafts is additionally configured to rotate about a respective second axis. The hollow templates are fitted on the respective rods or shafts and are each configured to contain a balloon-based distal end of a medical instrument, each template having a patterned opening through which one or more electrodes are deposited on the distal end.
Cavitary tissue ablation system
The invention is a system for monitoring and controlling tissue ablation. The system includes a controller configured to selectively control energy emission from an electrode array of an ablation device based on ablation feedback received during an ablation procedure with the ablation device. The controller is configured to receive feedback data from one or more sensors during the ablation procedure, the feedback data comprising one or more measurements associated with at least one of operation of the electrode array of the ablation device and tissue adjacent to the electrode array. The controller is further configured to generate an ablation pattern for controlling energy emission from the electrode array of the ablation device in response to the received feedback data.
Unmapped region visualization
A method, including capturing, from an imaging system, a three-dimensional (3D) image of a body cavity, and using the captured 3D image to construct a simulated surface of the body cavity. A probe having a location sensor is inserted into the body cavity, and in response to multiple location measurements received from the location sensor, multiple positions are mapped within respective regions of the body cavity so as to generate respective mapped regions of the simulated surface. Based on the simulated surface and the respective mapped regions, one or more unmapped regions of the simulated surface are delineated, and the simulated surface of the body cavity is configured to indicate the delineated unmapped regions.